Cervical cancer represents the second most common cancer in women worldwide
. About 90% of cervical cancer contain high-risk human papillomavirus (RPV)
DNA, most often HPV type 16. Animal models and mostly laboratory mice are
excellent for carrying out diverse immunological. studies. We transfected a
fibroblast cell line, 3T3-A31, with human papillomavirus type 16 genome to
develop an in vivo/in vitro malignant transformant model. Isolated clones
inoculated to immunocompetent mice displayed a tumorigenic phenotype. Small
clusters of metastatic cells were found in the liver of animal 45 days aft
er receiving the inoculum. Integrated viral DNA and expression of E7 viral
oncogene from the high-risk HPV-16 were demonstrated both in transfectans a
nd tumor-derived cells. The observed high-grade neovascularization was corr
elated with the upregulation of vascular endothelial growth factor (VEGF) m
RNA on HPV-16 transformed fibroblast cells. These observations emphasize th
e association between papillomavirus expression and progression to malignan
cy. (C) 2000 Academic Press.